ArticleEndocrine2026
A Hospital-Wide informatized glycemic management Team(WH-GMT) improves perioperative outcomes in type 2 diabetes: A prospective cohort study.
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeTo evaluate the effectiveness of the Hospital-Wide Informatized Glycemic Management Team (WH-GMT) model on perioperative outcomes in patients with type 2 diabetes mellitus (T2DM).
methodsThis prospective cohort study enrolled 360 T2DM patients scheduled for elective surgery. Participants were allocated to a control group (n = 132) receiving standard management or a WH-GMT group (n = 228). Outcomes were compared using multiple regression, mediation, and subgroup analyses.
resultsThe WH-GMT group demonstrated a significantly shorter median hospital stay [12.0 vs. 15.0 days, P < 0.001]. Both preoperative Time in Range (TIR) (56.5% vs. 45.5%, P = 0.001) and pre-discharge TIR (63.2% vs. 46.5%, P < 0.001) were significantly higher in the WH-GMT group. Hypoglycemic events (13.2% vs. 31.1%) and adverse events (4.8% vs. 14.4%) were significantly reduced in both cases (P < 0.01). WH-GMT was an independent factor for improved outcomes. Mediation analysis revealed that WH-GMT indirectly reduces adverse events by enhancing preoperative TIR, thereby reducing hospitalization duration. Subgroup analysis revealed the most pronounced benefit in patients with an HbA1c level of ≥ 9.1%, resulting in a 4.08-day reduction in stay (P < 0.001).
conclusionThe WH-GMT model effectively improves glycemic control, reduces complications, and shortens hospital stays for perioperative T2DM patients, with the most significant benefit in those with poor baseline control.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.